Plain-English translation of NCT07648706 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing two different ways of giving vitamin D3 supplements to pregnant women who have low vitamin D levels. Researchers want to see which dosing schedule works better at preventing preeclampsia, a serious pregnancy complication involving dangerously high blood pressure. Both groups will receive the medication alongside their regular pregnancy care.
Low vitamin D during pregnancy has been linked to preeclampsia and other serious health problems for both mothers and babies. However, doctors aren't sure what the best dose of vitamin D3 is to prevent these complications, so this study compares two different dosing approaches.
You likely qualify if…
You likely don't qualify if…
If you join this study, you'll be randomly assigned to take either a larger dose of vitamin D3 every two weeks or a smaller dose every week—both continuing until you deliver your baby. You'll continue your regular prenatal appointments and be monitored throughout your pregnancy for signs of preeclampsia and other health outcomes. The study will track your vitamin D levels and your baby's health as well.
AI-generated summary from trial data · Jul 4, 2026 · Not medical advice
Yemen